Sorrento Therapeutics Inc (SRNE): Pluristem today announced the failure of...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Monday, 12/27/2021 2:59:46 PM

Monday, December 27, 2021 2:59:46 PM

Pluristem today announced the failure of their phase 2 Covid ARDS trial. They tried placental derived cells. Sorrento has so far had far more encouraging results using body fat derived cells. COVI-MSC trials in the US and Brazil should report soon.

The Brazilian COVI-MSC trial is pivotal and another study with long-haul Covid patients is planned.

Abivertinib and COVI-MSC could be an important one/two punch to defeat Covid ARDS and ARDS in general.

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM